Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

PO Wealth Sharing Group Introduces Data-Driven Framework for U.S. Stock Market Analysis

August 25, 2026

Regula and WIDTH Help Compliance Teams Keep Identity Evidence Audit-Ready Beyond Onboarding

August 25, 2026

Q2 Metals Drills Best Hole to Date Intersecting 403.7 Metres at 1.57% Li₂O and 213.8 Metres at 1.93% Li₂O in Hole 93 at the Cisco Lithium Project

August 25, 2026

STARTRADER Adds 30 U.S. Stock and ETF CFDs as 2026 Product Expansion Accelerates

August 25, 2026

Cofiroute selects TomTom Traffic to enhance real-time motorway operations and driver information

August 25, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » SuspendIt® Is Now a USP Verified Excipient
Press Release

SuspendIt® Is Now a USP Verified Excipient

By News RoomDecember 10, 20252 Mins Read
SuspendIt® Is Now a USP Verified Excipient
Share
Facebook Twitter LinkedIn Pinterest Email

Houston, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) — PCCA, a leading supplier of pharmaceutical ingredients, announced today the U.S. Pharmacopeia (USP) has verified SuspendIt® — adding to its growing family of proprietary compounding bases that have earned this independent mark of quality assurance. Earlier this year, PCCA became the first FDA-registered supplier to complete the USP Ingredient Verification Program for Excipients for compounding bases, receiving verification for its LoxOral® and Anhydrous SuspendIt® bases.

“This verification demonstrates our continued commitment to our ‘Quality without Compromise’ core value,” said PCCA CEO Gus Bassani, PharmD. “Confirmation of quality through independent verification reinforces our promise to pharmacies and patients to deliver purity and consistency with our products. Our goal is to help our members compound with confidence.”

PCCA’s third USP Verified Excipient, SuspendIt®, is an all-in-one, aqueous compounding base that is specifically designed for oral suspension formulations. With its innovative technology, SuspendIt® enables rapid redispersion of APIs with gentle agitation, reduces sedimentation and helps support consistent dosing. Free of gluten, alcohol, parabens and dyes, SuspendIt® is suitable for a wide range of patients with sensitivity concerns.

“We are investing our time and efforts into completing the USP Verification process to verify the quality of our bases, even though regulations do not require it,” Bassani said. “We plan to continue pursuing this verification for additional PCCA proprietary bases.”

PCCA invests heavily in research and development to create unique, patented bases to enhance therapeutic outcomes, while providing independent compounding pharmacies and health systems with quality products, expert guidance and innovative approaches to delivering personalized medicine.

ABOUT PCCA
PCCA supports the creation of personalized medicine and innovative products that make a difference in patients’ lives. As a complete resource for independent compounding pharmacies and health systems, PCCA provides high-quality products, education and support to more than 3,000 pharmacy members throughout the United States, Canada, Australia and other countries around the world. Incorporated in 1981 by a network of pharmacists, PCCA has supported pharmacy compounding for more than 40 years. Learn more at pccarx.com.

  • SuspendIt® Is Now a USP Verified Excipient

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

PO Wealth Sharing Group Introduces Data-Driven Framework for U.S. Stock Market Analysis

Regula and WIDTH Help Compliance Teams Keep Identity Evidence Audit-Ready Beyond Onboarding

Q2 Metals Drills Best Hole to Date Intersecting 403.7 Metres at 1.57% Li₂O and 213.8 Metres at 1.93% Li₂O in Hole 93 at the Cisco Lithium Project

STARTRADER Adds 30 U.S. Stock and ETF CFDs as 2026 Product Expansion Accelerates

Cofiroute selects TomTom Traffic to enhance real-time motorway operations and driver information

Toobit Completes Expanded Penetration Tests with Hacken

Snoqualmie Casino & Hotel to Welcome 15 New Spooky Link™ Machines to Gaming Floor

Start of construction of the second part of the first stage of the Lucavsala residential project (Riga, Latvia)

GenZone Brings Dubai Business Setup and US LLC Formation Under One Platform

Editors Picks

Regula and WIDTH Help Compliance Teams Keep Identity Evidence Audit-Ready Beyond Onboarding

August 25, 2026

Q2 Metals Drills Best Hole to Date Intersecting 403.7 Metres at 1.57% Li₂O and 213.8 Metres at 1.93% Li₂O in Hole 93 at the Cisco Lithium Project

August 25, 2026

STARTRADER Adds 30 U.S. Stock and ETF CFDs as 2026 Product Expansion Accelerates

August 25, 2026

Cofiroute selects TomTom Traffic to enhance real-time motorway operations and driver information

August 25, 2026

Latest News

Toobit Completes Expanded Penetration Tests with Hacken

August 25, 2026

Snoqualmie Casino & Hotel to Welcome 15 New Spooky Link™ Machines to Gaming Floor

August 25, 2026

Start of construction of the second part of the first stage of the Lucavsala residential project (Riga, Latvia)

August 25, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version